📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells. (2024)

First Author: Madan E

Attributed to: Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41587-024-02453-3

PubMed Identifier: 39653752

Publication URI: http://europepmc.org/abstract/MED/39653752

Type: Journal Article/Review

Parent Publication: Nature biotechnology

ISSN: 1087-0156